📰 Calgary Stroke Program News
Calgary Stroke Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Calgary Stroke Program. Real-time updates on events, politics, business and more.
October 28, 2023
"What we dont know can hurt us." Thats from a new poll from the Heart and Stroke Foundation, which shows many Canadians are in the dark when it comes to the signs, symptoms and risks surrounding heart disease and stroke.
July 12, 2023
Tenecteplase confers similar reperfusion, safety, and functional outcomes as alteplase in patients with large-vessel occlusion stroke, new research shows.
May 5, 2023
Experts explain the evolution of virtual reality in the neurorehabilitation space and its application across different patient populations.
May 16, 2021
Dr. Ben Chan remembers hearing the preliminary reports back in March of blood clots appearing in a handful of European recipients of the Oxford-AstraZeneca COVID-19 vaccine.
May 16, 2021
Science on COVID, VITT constantly changing: A look at how doctors keep up Poll Independent A vial of AstraZeneca vaccine is seen at a mass COVID-19 vaccination clinic in Calgary, Alta., Thursday, April 22, 2021. Dr. Ben Chan remembers hearing the preliminary reports back in March of blood clots appearing in a handful of European recipients of the Oxford-AstraZeneca COVID-19 vaccine. THE CANADIAN PRESS/Jeff McIntosh Dr. Ben Chan remembers hearing the preliminary reports back in March of blood cl...
May 16, 2021
Science on COVID, VITT constantly changing: A look at how doctors keep up by Melissa Couto Zuber, The Canadian Press Posted May 16, 2021 8:00 am EDT Last Updated May 16, 2021 at 8:14 am EDT A vial of AstraZeneca vaccine is seen at a mass COVID-19 vaccination clinic in Calgary, Alta., Thursday, April 22, 2021.THE CANADIAN PRESS/Jeff McIntosh Dr. Ben Chan remembers hearing the preliminary reports back in March of blood clots appearing in a handful of European recipients of the Oxford-AstraZeneca ...
May 16, 2021
Dr. Ben Chan remembers hearing the preliminary reports back in March of blood clots appearing in a handful of European recipients of the Oxford-AstraZeneca COVID-19 vaccine. The global health expert with the University of Toronto followed the developments closely over ensuing weeks as researchers went from examining what was going on to determining how to diagnose and treat it. The disorder, characterized by low platelet counts, is now called vaccine-induced thrombotic thrombocytopenia, o...